Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Lotus Pharmaceutical (1795 TT)
Watchlist
41
Analysis
Health Care
•
Taiwan
Lotus Pharmaceutical Co., Ltd. manufactures and distributes oral medicine, ointment and injection medicine.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
28 May 2023 10:05
TWSE Short Interest Weekly (May 26th): Wistron, Yageo, Chunghwa Telecom, Wiwynn, Global Unichip
We analyzed TWSE short interest report for the past week and highlight short interest changes in Wistron, Yageo, Chunghwa Telecom, Wiwynn, Global...
Ke Yan, CFA, FRM
Follow
509 Views
Share
bearish
•
Quantitative Analysis
•
21 May 2023 10:00
TWSE Short Interest Weekly (May 19th): Wistron, Lotus, Yageo, Mediatek, Tatung, Cathay Financial
We analyzed TWSE short interest report for the past week and highlight short interest changes in Wistron, Lotus, Yageo, Mediatek, Tatung, Cathay...
Ke Yan, CFA, FRM
Follow
437 Views
Share
bearish
•
Quantitative Analysis
•
13 Feb 2023 08:00
TWSE Short Interest Weekly (Feb 10th): Evergreen Marine, Unimicron Tech, Novatek
We analyzed TWSE short interest report for the past week and highlight short interest changes in Evergreen Marine, Unimicron Tech, Novatek.
Ke Yan, CFA, FRM
Follow
462 Views
Share
bullish
•
Lotus Pharmaceutical
•
05 Feb 2023 15:20
Lotus Pharmaceutical (1795 TT): 2022 Ends with Mid-Teen Revenue Growth; Further Steam Still Left
Driven by lenalidomide launch in US, 2022 revenue grew 16%, marking 3rd consecutive year of double-digit growth. New product introduction and...
Tina Banerjee
Follow
537 Views
Share
bullish
•
Quantitative Analysis
•
03 Jan 2023 08:00
TWSE Short Interest Weekly (Dec 30th): Biggest Short Covers in a Year
We analyzed TWSE short interest report for the past week and highlight short interest changes in China Steel, Taiwan Cement, Cathay Financial, Yang...
Ke Yan, CFA, FRM
Follow
546 Views
Share
First
Previous
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x